ArticleFrontiers in oncology2026

Efficacy of an XPO1 inhibitor in combination with irinotecan in a preclinical colorectal cancer model.

Robert W Lentz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.